BackStoke Therapeutics Overview

Stoke Therapeutics Receivables

Latest receivables for STOK: $6.1M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$6.14M
↑ 913.37% YoYΔ $5.54M vs prior year quarter

Peer average

Loading

Stoke Therapeutics Receivables History

Loading

Stoke Therapeutics vs. peers: Receivables Comparison

Loading

Stoke Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Stoke Therapeutics (STOK) FAQ

As of the most recent data (March 2026), STOK shows a receivables of $6.1M. That compares with $610K in the prior-year period — up 913.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, STOK's receivables is now $6.1M (was $610K) — a 913.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Stoke Therapeutics is outperforming or lagging.

Tracking STOK's receivables over time shows whether Stoke Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $6.1M That compares with $610K in the prior-year period — up 913.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Stoke Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $6.1M) with ownership activity and broader fundamentals.

Stoke Therapeutics's receivables is $6.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.